PINK:COEP

Coeptis Therapeutics Stock Insider Trading

etoro logo Buy COEP
*Your capital is at risk
$16.40
+0 (+0%)
At Close: Jun 03, 2026

Coeptis Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.02M and sold 1.4M COEP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 3.02M shares
Sell 1.4M shares
98% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 24, 2026
Buy
Common Stock, par value $0.0001 per share
Bsg Series Cm, Llc
10 Percent Owner
10% Owner 0
Value: $0
Feb 11, 2026
Buy
Common stock
M-Exempt
Cogley Brian
Chief Financial Officer
C-Suite Officer 10 000
Value: $105.6K
Feb 11, 2026
Buy
Common Stock
A-Award
Cogley Brian
Chief Financial Officer
C-Suite Officer 12 500
Value: $149.9K
Feb 11, 2026
Buy
Common stock
M-Exempt
Deschamps Philippe
Director
Director 5 700
Value: $60.2K
Feb 11, 2026
Buy
Common Stock
A-Award
Deschamps Philippe
Director
Director 3 250
Value: $39.0K
Feb 11, 2026
Buy
Common stock
M-Exempt
Calise Chris
Director
Director 5 700
Value: $60.2K
Feb 11, 2026
Buy
Common stock
A-Award
Calise Chris
Director
Director 3 250
Value: $39.0K
Feb 11, 2026
Buy
Common stock
M-Exempt
Mehalick David
CEO And President
CEO / President 148 875
Value: $1.05M
Feb 11, 2026
Buy
Common Stock
A-Award
Mehalick David
CEO And President
CEO / President 51 250
Value: $614.5K
Feb 11, 2026
Buy
Common stock
M-Exempt
Cochran Christopher P.
Director
Director 5 700
Value: $60.2K
Feb 11, 2026
Buy
Common Stock
A-Award
Cochran Christopher P.
Director
Director 3 250
Value: $39.0K
Feb 11, 2026
Buy
Common stock
M-Exempt
Yerace Daniel Alexander
Vp Operations
Officer 10 000
Value: $104.1K
Feb 11, 2026
Buy
Common Stock
A-Award
Yerace Daniel Alexander
Vp Operations
Officer 20 000
Value: $239.8K
Feb 11, 2026
Buy
Common stock
M-Exempt
Salkind Gene
Director
Director 5 700
Value: $60.2K
Feb 11, 2026
Buy
Common Stock
A-Award
Salkind Gene
Director
Director 3 250
Value: $39.0K
Feb 11, 2026
Buy
Common stock
M-Exempt
Desilva Tara
Director
Director 5 700
Value: $60.2K
Feb 11, 2026
Buy
Common Stock
A-Award
Desilva Tara
Director
Director 3 250
Value: $39.0K
Feb 11, 2026
Buy
Common stock
M-Exempt
Sheehy Christine Elise
Vp Compliance And Secy
Officer 1 000
Value: $10.6K
Feb 11, 2026
Buy
Common Stock
A-Award
Sheehy Christine Elise
Vp Compliance And Secy
Officer 12 500
Value: $149.9K
Mar 04, 2025
Buy
Non-qualified Stock Options (right to buy)
A-Award
Deschamps Philippe
Director
Director 5 700
Value: $60.2K
Mar 04, 2025
Buy
Non-qualified Stock Options (right to buy)
A-Award
Deschamps Philippe
Director
Director 5 700
Value: $60.2K
Mar 04, 2025
Buy
Non-Qualified Stock Options (right to buy)
A-Award
Cogley Brian
Chief Financial Officer
C-Suite Officer 10 000
Value: $105.6K
Mar 04, 2025
Buy
Non-Qualified Stock Options (right to buy)
A-Award
Yerace Daniel Alexander
Vp Of Operations
Officer 5 000
Value: $52.8K
Mar 04, 2025
Buy
Non-Qualified Stock Options (right to buy)
A-Award
Sheehy Christine Elise
Vp Compliance And Secy
Officer 1 000
Value: $10.6K
Mar 04, 2025
Buy
Non-qualified Stock Options (right to buy)
A-Award
Salkind Gene
Director
Director 5 700
Value: $60.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT COEPTIS THERAPEUTICS INC.
Coeptis Therapeutics
Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the abilit...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE